Association of the Outcome of Renal Transplantation with Antibody Response to Cytomegalovirus Strain--Specific Glycoprotein H Epitopes | Zendy

Kenichi Ishibashi | Zendy; Tadahiko Tokumoto | Zendy; K. Tanabe | Zendy; Hiroki Shirakawa | Zendy; Koichi Hashimoto | Zendy; Nobuhiro Kushida | Zendy; Takeshi Yanagida | Zendy; Naoki Inoue | Zendy; Osamu Yamaguchi | Zendy; Hiroshi Toma | Zendy; Tatsuo Suzutani | Zendy

Open Access

Association of the Outcome of Renal Transplantation with Antibody Response to Cytomegalovirus Strain--Specific Glycoprotein H Epitopes

Author(s) -

Kenichi Ishibashi,

Tadahiko Tokumoto,

K. Tanabe,

Hiroki Shirakawa,

Koichi Hashimoto,

Nobuhiro Kushida,

Takeshi Yanagida,

Naoki Inoue,

Osamu Yamaguchi,

Hiroshi Toma,

Tatsuo Suzutani

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/518571

Subject(s) - medicine , cytomegalovirus , transplantation , immunology , betaherpesvirinae , human cytomegalovirus , antibody , epitope , herpesviridae , virology , viral disease , virus

Cytomegalovirus (CMV) is the most important pathogen affecting the outcome of renal transplantation. The combination of CMV-seronegative transplant recipients with CMV-seropositive transplant donors places recipients at the highest risk of CMV disease. In cases of congenital CMV infection, existing immunity only partially protected mothers from reinfection with a different genotypic strain. The effect of differences in infected CMV strains between CMV-seropositive transplant donors and CMV seropositive transplant recipients on the outcome of transplantation remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research